Rademikibart demonstrated rapid and significant improvement in lung function and asthma control in patients, with greatest improvements observed in those with elevated baseline levels of key type 2 ...
Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback